Ewing sarcoma, primary site (Q38773): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Tumor de pequenas células redondas em que falta evidência morfológica, imunohistoquímica e à microscopia eletrônica de diferenciação neuroectodérmica. Ele representa uma das duas extremidades do espectro chamado sarcoma de Ewing/tumor neuroectodérmico periférico. Afeta majoritariamente homens abaixo de 20 anos de idade, e pode ocorrer em tecidos moles ou osso. Dor e a presença de uma massa são os sintomas clínicos mais frequentes. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A small round cell tumour that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing's sarcoma/peripheral neuroectodermal tumour. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1651102476 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:2B52 | |||||||||||||||
| Property / CURIE: CID11:2B52 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-2B52 | |||||||||||||||
| Property / Canary Token: dki-india-2B52 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: C41.9 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 03:58, 13 August 2026
A small round cell tumour that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing's sarcoma/peripheral neuroectodermal tumour. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2B52 |
||
| English | Ewing sarcoma, primary site |
A small round cell tumour that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing's sarcoma/peripheral neuroectodermal tumour. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms. |
Statements
CID11:2B52
0 references
dki-india-2B52
0 references
Concluído
0 references
13 August 2026
0 references
